Parkinson-Lawrence Emma, Turner Christopher, Hopwood John, Brooks Doug
Lysosomal Diseases Research Unit, Department of Genetic Medicine, Women's and Children's Hospital, 72 King William Rd, North Adelaide, South Australia 5006, Australia.
Biochem J. 2005 Mar 1;386(Pt 2):395-400. doi: 10.1042/BJ20040739.
Mammalian sulphatases (EC 3.1.6) are a family of enzymes that have a high degree of similarity in amino acid sequence, structure and catalytic mechanism. IDS (iduronate-2-sulphatase; EC 3.1.6.13) is a lysosomal exo-sulphatase that belongs to this protein family and is involved in the degradation of the glycosaminoglycans heparan sulphate and dermatan sulphate. An IDS deficiency causes the lysosomal storage disorder MPS II (mucopolysaccharidosis type II). To examine the structural alterations in heat-denatured and mutant IDS, a panel of four monoclonal antibodies was raised to the denatured protein and used as probes of protein conformation. The linear sequence epitope reactivity of a polyclonal antibody raised against the native protein and the monoclonal antibodies were defined and mapped to distinct regions on the IDS protein. The antigenicity of native IDS was higher in regions without glycosylation, but reactivity was not restricted to protein surface epitopes. One monoclonal epitope was relatively surface accessible and in close proximity to an N-linked glycosylation site, while three others required additional thermal energy to expose the epitopes. The monoclonal antibodies demonstrated the capacity to differentiate progressive structural changes in IDS and could be used to characterize the severity of MPS type II in patients based on variable denatured microstates.
哺乳动物硫酸酯酶(EC 3.1.6)是一类在氨基酸序列、结构和催化机制上具有高度相似性的酶。艾杜糖醛酸-2-硫酸酯酶(IDS;EC 3.1.6.13)是一种溶酶体外硫酸酯酶,属于该蛋白家族,参与糖胺聚糖硫酸乙酰肝素和硫酸皮肤素的降解。IDS缺乏会导致溶酶体贮积症II型(MPS II,黏多糖贮积症II型)。为了研究热变性和突变型IDS的结构改变,制备了一组针对变性蛋白的四种单克隆抗体,并将其用作蛋白质构象的探针。定义了针对天然蛋白产生的多克隆抗体和单克隆抗体的线性序列表位反应性,并将其定位到IDS蛋白上的不同区域。天然IDS在无糖基化的区域抗原性较高,但反应性并不局限于蛋白质表面表位。一个单克隆表位相对位于表面且靠近一个N-连接糖基化位点,而其他三个表位则需要额外的热能来暴露表位。这些单克隆抗体显示出能够区分IDS中渐进性结构变化的能力,可用于根据可变的变性微状态来表征II型MPS患者的严重程度。